Table 1 Study Characteristics
Study | Intervention | # Treated | # Controls | Patient Population | Double Blinding |
|---|---|---|---|---|---|
Groothuis 1993 | RSV-IGIV 750 mg/kg | 81 | 89 | Premature, CLD, CHD | No |
PREVENT 1997 | RSV-IGIV 750 mg/kg | 250 | 260 | Premature, CLD | Yes |
Simoes 1998 | RSV-IGIV 750 mg/kg | 202 | 214 | CHD | No |
Subramanian 1998 | Palivizumab 15 mg/kg | 22 | 20 | Premature, CLD | Yes |
IMPACT 1998 | Palivizumab 15 mg/kg | 1002 | 500 | Premature, CLD | Yes |
Feltes 2003 | Palivizumab 15 mg/kg | 639 | 648 | CHD | Yes |